|
|
Post by itellthefuture777 on Jan 27, 2019 22:12:57 GMT -5
www.nobleconference.com/NobleCon15/agenda.htmTuesday, January 29, 2019 - DAY TWO NobleCon15 - W Fort Lauderdale Conference Level 2nd Level 7:30am - NobleCon15 Check-in Opens 7:45am - Continental Breakfast Served 8:30am - PANEL PRESENTATION - Studio 1 - Diabetes: Is a cure for the disease closer than we think? Panelists Camillo Ricordi, MD, Director, Diabetes Research Institute, Noble S.A.B. MemberSteve Perrin, PhD, Chief Executive Officer and Founder, Anelixis Therapeutics, LLC (Private)William L. Rust, PhD, Chief Executive Officer and Founder, Seraxis, Pte. Ltd. (Private)Michael Fox, MS, RDN, LN, Michael Fox, DugalHealth L.L.C. (Private)Martin Beland, Vice President of Marketing and Strategic Development, Inolife Sciences (Private)Philip Toleikis, PhD, President and Chief Executive Officer, Sernova Corp. (TSXV:SVA)Steve Glover, Chief Executive Officer, Chairman, and Co-Founder, Variant Pharmaceuticals, Inc. (Private)Michael Castagna, PharmD, MannKind Corporation (NasdaqGM:MNKD)
|
|
|
|
Post by goyocafe on Jan 27, 2019 23:27:08 GMT -5
Why doesn’t Mannkind talk about these activities?
|
|
|
|
Post by mango on Jan 28, 2019 0:04:31 GMT -5
Why doesn’t Mannkind talk about these activities? We do everything in stealth mode these days 😶 |
|
|
|
Post by matt on Jan 28, 2019 8:19:27 GMT -5
Why doesn’t Mannkind talk about these activities? This type of conference is mostly to connect micro-cap companies with investors for their next financing round. It is not like the JP Morgan conference where it is mainly industry players potentially looking for acquisition and/or partnering opportunities. For example, one of the keynote speakers is Josh Scheinfeld who was a founder of Fusion Capital and later Lincoln Park Capital, both hard money investors that specialized in Rule 415 offerings. If you look at the history of Fusion and Lincoln Park you will find a dearth of quality deals and lots of biotech disasters that got crushed by serial dilution. Rule 415 offerings almost always end badly for the company. This conference attracts predatory investors, not high-quality funds. It is not something you want to promote. |
|
|
|
Post by awesomo on Jan 28, 2019 8:51:51 GMT -5
Every other company on the massive panel is private, except for Sernova, which is a penny stock (currently at 0.13). Maybe Mike got the benefit of doubt before, but this doesn’t seem like great company here.
|
|
|
|
Post by #NoMoreNeedles on Jan 28, 2019 9:30:53 GMT -5
Last time they presented at NobleCon in January 2018 this was followed by an offering in April!
|
|
|
|
Post by harryx1 on Jan 28, 2019 11:22:06 GMT -5
|
|
|
|
Post by Thundersnow on Jan 28, 2019 12:14:14 GMT -5
Last time they presented at NobleCon in January 2018 this was followed by an offering in April! They are not presenting therefore I doubt an offering is coming. Also MNKD will not tell their competitors what they are doing. No need for a press release. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 28, 2019 14:13:42 GMT -5
Every other company on the massive panel is private, except for Sernova, which is a penny stock (currently at 0.13). Maybe Mike got the benefit of doubt before, but this doesn’t seem like great company here. MC needs to play nice in the sandbox, just in case. If it ever got to the point of lender of last resort and a choice of dealing with these folks or closing the doors.... Always better to have more options than less. |
|
|
|
Post by goyocafe on Jan 28, 2019 14:34:37 GMT -5
Every other company on the massive panel is private, except for Sernova, which is a penny stock (currently at 0.13). Maybe Mike got the benefit of doubt before, but this doesn’t seem like great company here. MC needs to play nice in the sandbox, just in case. If it ever got to the point of lender of last resort and a choice of dealing with these folks or closing the doors.... Always better to have more options than less. Wasn’t it just a few of months ago we heard that MNKD was having to hand pick opportunities that had financial backing due to the number of opportunities being presented to them. I’m hard pressed to think toxic funding is a sandbox they need to play in with so many sources for funding. |
|
|
|
Post by mnholdem on Jan 28, 2019 14:49:42 GMT -5
Yep. As a shareholder I would expect a much-improved balance sheet would attract higher quality financiers if additional capital were needed. So why continue to swim with the sharks?
|
|
|
|
Post by mango on Jan 28, 2019 15:05:52 GMT -5
Yep. As a shareholder I would expect a much-improved balance sheet would attract higher quality financiers if additional capital were needed. So why continue to swim with the sharks? Stockholm Syndrome? |
|
|
|
Post by markado on Jan 28, 2019 16:30:46 GMT -5
Given the topic re: a cure for diabetes..maybe Mike's there to present the next best, cost effective alternative, even if/when a "cure" is presented.
|
|
|
|
Post by goyocafe on Jan 28, 2019 18:03:26 GMT -5
|
|
|
|
Post by sportsrancho on Jan 28, 2019 18:04:01 GMT -5
Mike is not going.
|
|
